Clinical Trials Browser

Phase 2 × INDUSTRY × Vasomotor Symptoms (VMS) × Clear all

NCT03518138 2021-07-23

Safety/Efficacy of Q-122 in Breast Cancer Patients Taking Tamoxifen or Aromatase Inhibitor

Phase 2 Completed

Vasomotor Symptoms (VMS)